⚖️DEA Revocation of Joely Keen's Registration
The Drug Enforcement Administration has revoked Joely Keen's DEA registration after finding that she lacks the necessary state authority to handle controlled substances in Texas. This decision stems from the revocation of her nursing licenses and failure to maintain a prescriptive authority agreement, highlighting the importance of compliance in the healthcare field.
Learn More🚫Revocation of DEA Registration for Physician in Georgia
The Drug Enforcement Administration has revoked Dr. Harvey Leslie's DEA registration due to his inability to prescribe controlled substances after the revocation of his Georgia medical license. The document outlines the regulatory process leading to this decision and the implications of default by the registrant.
Learn More💰SBA Notice on Exemption Request for LCM Healthcare Fund
This notice from the Small Business Administration informs that LCM Healthcare Fund I, L.P. is seeking an exemption related to equity financing terms with Northwest Surgical Development Company. A public comment period is established for interested parties regarding this financing decision.
Learn More🚚Renewal of Exemptions for Drivers with Seizure Disorders
FMCSA corrects its January 6, 2025, notice requesting comments for 19 individuals to renew exemptions from the Agency's requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) that interstate commercial motor vehicle (CMV) drivers have no established medical history or clinical diagnosis of epilepsy or any other condition which is likely to cause loss of consciousness or any loss of ability to control a CMV. An individual's name was misspelled, and this notice corrects that error.
Learn More🚫DEA Revocation Order for Dr. Thomas Andr'e Endicott, D.D.S.
The Drug Enforcement Administration has revoked the DEA registration of Thomas Andr'e Endicott, D.D.S., due to the revocation of his dental and controlled substance licenses in Utah. This decision highlights the necessity for practitioners to maintain state licensing to uphold their DEA registrations, emphasizing regulatory compliance in the healthcare field.
Learn More📊CMS Notice on Information Collection Activities and Public Comments
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Learn More💉Notice of Closed Meeting for Diabetes Research Grants Evaluation
The Department of Health and Human Services announces a closed meeting by the National Institutes of Health to review grant applications related to diabetes, digestive, and kidney diseases. The meeting, which will occur virtually, aims to protect sensitive information, including potential trade secrets and personal privacy concerns, making it closed to the public.
Learn More🏥NIH Meeting on Arthritis Research Grants
The Department of Health and Human Services announces a public meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. The meeting will encompass discussions on grant applications and an open session for community engagement, providing valuable opportunities for stakeholders in health research and development.
Learn More🩺National Cancer Institute Announces Grant Application Review Meetings
The National Cancer Institute is holding closed meetings to evaluate grant applications related to cancer research. These meetings will occur virtually, providing key insights into funding opportunities for businesses involved in this critical area of healthcare. Interested individuals can contact designated scientific review officers for more information.
Learn More💊Expansion of Buprenorphine Treatment via Telemedicine Regulations
In the January 17, 2025, issue of the Federal Register, the Drug Enforcement Administration and the Department of Health and Human Services published two final rules related to the practice of telemedicine, titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients." These final rules were originally scheduled to become final on February 18, 2025. In accordance with the Presidential Memorandum of January 20, 2025, titled "Regulatory Freeze Pending Review," the Drug Enforcement Administration and the Department of Health and Human Services delayed the effective dates of these two final rules to March 21, 2025, by issuing a final rule; delay of effective dates and request for comments in the February 19, 2025, issue of the Federal Register. The Drug Enforcement Administration received 32 comments in response to the request for public comments regarding the delayed effective date. Considering these comments, the Department of Justice wishes to further postpone the effective dates for the purpose of further reviewing any questions of fact, law, and policy that the rules may raise. Therefore, the Drug Enforcement Administration and the Department of Health and Human Services will delay the effective date of the two final rules titled "Expansion of Buprenorphine Treatment via Telemedicine Encounter" and "Continuity of Care via Telemedicine for Veterans Affairs Patients" to December 31, 2025.
Learn More